MLL: A histone methyltransferase disrupted in leukemia

Trends in Molecular Medicine

Volumn 10, Issue 10, 2004, Pages 500-507

  Hess, Jay L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE; HISTONE; HISTONE ACETYLTRANSFERASE PCAF; HISTONE DEACETYLASE; HOMEODOMAIN PROTEIN; HYBRID PROTEIN; METHIONINE; METHYLTRANSFERASE; MIXED LINEAGE LEUKEMIA PROTEIN; MYC PROTEIN; TUMOR SUPPRESSOR PROTEIN;

BINDING SITE; BONE MARROW CELL; CARBOXY TERMINAL SEQUENCE; CELL FATE; CHROMATIN; CHROMOSOME 11Q; DNA BINDING; DNA METHYLATION; DNA SEQUENCE; FUSION GENE; GENE AMPLIFICATION; GENE CLUSTER; GENE CONTROL; GENE DISRUPTION; GENE DUPLICATION; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; GENE REARRANGEMENT; GENE TARGETING; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HOMEOBOX; HOX GENE; LEUKEMIA; LYMPHOID CELL; MOLECULAR MECHANICS; NONHUMAN; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SEQUENCE HOMOLOGY; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; UPREGULATION;

DNA-BINDING PROTEINS; GENE AMPLIFICATION; GENE DUPLICATION; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; LEUKEMIA; MODELS, GENETIC; MYELOID-LYMPHOID LEUKEMIA PROTEIN; PROTO-ONCOGENES; RECOMBINANT FUSION PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 4644220954     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2004.08.005     Document Type: Review

References (69)

1. P.M. Ayton, and M.L. Cleary Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins Oncogene 20 2001 5695 5707
2. P.M. Ayton, and M.L. Cleary MLL in normal and malignant hematopoiesis K. Ravid J.D. Licht Transcription Factors Normal and Malignant Development of Blood Cells 2001 Wiley-Liss 447 464
3. Felix, C.A. et al. (2000) Pediatric acute lymphoblastic leukemia: Challenges and controversies in 2000. Hematology (Am. Soc. Hematol. Educ. Program), 285-302
4. K. Lochner A specific deletion in the breakpoint cluster region of the ALL-1 gene is associated with acute lymphoblastic T-cell leukemias Cancer Res. 56 1996 2171 2177
5. C.A. Felix Secondary leukemias induced by topoisomerase-targeted drugs Biochim. Biophys. Acta 1400 1998 233 255
6. D. Grimwade The importance of diagnostic cytogenetics in outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukemia Working Parties Blood 92 1998 2322 2333
7. S.A. Schichman ALL-1 partial duplication in acute leukemia Proc. Natl. Acad. Sci. U. S. A. 91 1994 6236 6239
8. B. Poppe Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies Blood 103 2004 229 235
9. H.W. Brock, and M. van Lohuizen The Polycomb group - no longer an exclusive club? Curr. Opin. Genet. Dev. 11 2001 175 181
10. J.L. Hess Defects in yolk sac hematopoiesis in Mll-null embryos Blood 90 1997 1799 1806
11. H. Yagi Growth disturbance in fetal liver hematopoiesis of Mll-mutant mice Blood 92 1998 108 117
12. P. Ernst Definitive hematopoiesis requires the mixed-lineage leukemia gene Dev. Cell 6 2004 437 443
13. B.D. Yu Altered Hox expression and segmental identity in Mll-mutant mice Nature 378 1995 505 508
14. J.J. Hsieh Proteolytic cleavage of MLL generates a complex of N- and C-terminal fragments that confers protein stability and subnuclear localization Mol. Cell. Biol. 23 2003 186 194
15. J.J. Hsieh Taspase1: a threonine aspartase required for cleavage of MLL and proper HOX gene expression Cell 115 2003 293 303
16. T. Nakamura The ALL-1 protein is a histone H3- lysine 4 methyltransferase and assembles a supercomplex of proteins involved in chromatin alterations and in core promoter recognition Mol. Cell 10 2002 1119 1128
17. A. Yokoyama Leukemia proto-oncoprotein MLL is proteolytically processed into two fragments with opposite transcriptional properties Blood 100 2002 3710 3718
18. T. Yano Nuclear punctate distribution of ALL-1 is conferred by distinct elements at the N terminus of the protein Proc. Natl. Acad. Sci. U. S. A. 94 1997 7286 7291
19. M. Birke The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation Nucleic Acids Res. 30 2002 958 965
20. A. Yokoyama Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression Mol. Cell. Biol. 24 2004 5639 5649
21. C.M. Hughes Menin associates with a trithorax family methyltransferase complex and with the Hoxc8 locus Mol. Cell 13 2004 587 597
22. Z.B. Xia MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein Proc. Natl. Acad. Sci. U. S. A. 100 2003 8342 8347
23. K. Fair Protein interactions of the MLL PHD fingers modulate MLL target gene regulation in human cells Mol. Cell. Biol. 21 2001 3589 3597
24. P. Ernst MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein Mol. Cell. Biol. 21 2001 2249 2258
25. T.A. Milne MLL targets SET domain methyltransferase activity to Hox gene promoters Mol. Cell 10 2002 1107 1117
26. M. Lachner, and T. Jenuwein The many faces of histone lysine methylation Curr. Opin. Cell Biol. 14 2002 286 298
27. J. Muller Histone methyltransferase activity of a Drosophila polycomb group repressor complex Cell 111 2002 197 208
28. A. Kuzmichev Histone methyltransferase activity associated with a human multi-protein complex containing the enhancer of Zeste Protein Genes Dev. 16 2002 2893 2905
29. B. Czermin Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal polycomb sites Cell 111 2002 185 196
30. R. Cao Role of histone H3 lysine 27 methylation in Polycomb-group silencing Science 298 2002 1039 1043
31. P. Zegerman Histone H3 lysine 4 methylation disrupts binding of nucleosome remodeling and deacetylase (NuRD) repressor complex J. Biol. Chem. 277 2002 11621 11624
32. H. Santos-Rosa Methylation of histone H3 K4 mediates association of the Isw1p ATPase with chromatin Mol. Cell 12 2003 1325 1332
33. N.J. Krogan The Paf1 complex is required for histone H3 methylation by COMPASS and Dot1p: linking transcriptional elongation to histone methylation Mol. Cell 11 2003 721 729
34. O. Rozenblatt-Rosen The C-terminal SET domains of ALL-1 and TRITHORAX interact with the INI1 and SNR1 proteins, components of the SWI/SNF complex Proc. Natl. Acad. Sci. U. S. A. 95 1998 4152 4157
35. J. Corral An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes Cell 85 1996 853 861
36. C.L. Dobson The mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis EMBO J. 18 1999 3564 3574
37. C. Lavau Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL EMBO J. 16 1997 4226 4237
38. B.B. Zeisig Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization Mol. Cell. Biol. 24 2004 617 628
39. M.E. Martin Dimerization of MLL fusion proteins immortalizes hematopoietic cells Cancer Cell 4 2003 197 207
40. R.K. Slany The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX Mol. Cell. Biol. 18 1998 122 129
41. C.W. So Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias Cancer Cell 4 2003 99 110
42. S.A. Schreiner The leukemogenic fusion of MLL with ENL creates a novel transcriptional transactivator Leukemia 13 1999 1525 1533
43. B.B. Zeisig Transcriptional activation is a key function encoded by MLL fusion partners Leukemia 17 2003 359 365
44. Z. Nie Novel SWI/SNF chromatin-remodeling complexes contain a mixed-lineage leukemia chromosomal translocation partner Mol. Cell. Biol. 23 2003 2942 2952
45. S. Debernardi The MLL fusion partner AF10 binds GAS41, a protein that interacts with the human SWI/SNF complex Blood 99 2002 275 281
46. F. Erfurth MLL fusion partners AF4 and AF9 interact at subnuclear foci Leukemia 18 2004 92 102
47. C. Lavau Chromatin-related properties of CBP fused to MLL generated a myelodysplastic-like syndrome that evolves into myeloid leukemia EMBO J. 19 2000 4655 4664
48. C.W. So, and M.L. Cleary Common mechanism for oncogenic activation of MLL by forkhead family proteins Blood 101 2003 633 639
49. C.W. So, and M.L. Cleary MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function Mol. Cell. Biol. 22 2002 6542 6552
50. kip1 Nature 404 2000 782 787
51. A. Shilatifard An RNA polymerase II elongation factor encoded by the human ELL gene Science 271 1996 1873 1876
52. J. DiMartino A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL Blood 96 2000 3887 3893
53. R.T. Luo The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis Mol. Cell. Biol. 21 2001 5678 5687
54. C.L. Dobson Tumorigenesis in mice with a fusion of the leukaemia oncogene Mll and the bacterial lacZ gene EMBO J. 19 2000 843 851
55. Ross, M.E. et al. (2004) Gene expression profiling of pediatric acute myelogenous leukemia. Blood Jun 29 [E published ahead of print]
56. U. Thorsteinsdottir Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion Blood 99 2002 121 129
57. G. Sauvageau Homeobox gene networks and the regulation of hematopoiesis K. Ravid J.D. Licht Transcription Factors in Normal and Malignant Development of Blood Cells 2001 Wiley Liss 133 148
58. N. Pineault Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny Exp. Hematol. 30 2002 49 57
59. T. Nakamura Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias Nat. Genet. 12 1996 149 153
60. J.J. Moskow Meis1, a PBX1-related homeobox gene involved in myeloid leukemia in BXH-2 mice Mol. Cell. Biol. 15 1995 5434 5443
61. E. Kroon Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b EMBO J. 17 1998 3714 3725
62. C.A. Schnabel HoxA9-mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis Oncogene 19 2000 608 616
63. S.A. Armstrong MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia Nat. Genet. 30 2002 41 47
64. T. Rozovskaia Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4;11) abnormality Oncogene 20 2001 874 878
65. E.J. Yeoh Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling Cancer Cell 1 2002 133 143
66. A.A. Ferrando Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation Blood 102 2003 262 268
67. P.M. Ayton, and M.L. Cleary Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9 Genes Dev. 17 2003 2298 2307
68. C.W. So Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9 Blood 103 2003 3192 3199
69. A.R. Kumar Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia Blood 103 2003 1823 1828